A Randomized Phase III Trial Of Thalidomide (NSC # 66847) Plus Dexamethasone Versus Dexamethasone In Newly Diagnosed Multiple Myeloma
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Dexamethasone (Primary) ; Thalidomide (Primary) ; Pamidronic acid; Zoledronic acid
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- 04 Oct 2005 New trial record.